153 related articles for article (PubMed ID: 38378033)
21. DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases.
Rata M; Khan K; Collins DJ; Koh DM; Tunariu N; Bali MA; d'Arcy J; Winfield JM; Picchia S; Valeri N; Chau I; Cunningham D; Fassan M; Leach MO; Orton MR
Cancer Imaging; 2021 Dec; 21(1):67. PubMed ID: 34924031
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
Neubauer H; Li M; Müller VR; Pabst T; Beer M
Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
[No Abstract] [Full Text] [Related]
24. Diffusion-weighted MRI Is Superior to PET/CT in Predicting Survival of Patients Undergoing
Barabasch A; Heinzel A; Bruners P; Kraemer NA; Kuhl CK
Radiology; 2018 Sep; 288(3):764-773. PubMed ID: 29786487
[TBL] [Abstract][Full Text] [Related]
25. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
[TBL] [Abstract][Full Text] [Related]
26. Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?
Kim SS; Song KD; Kim YK; Kim HC; Huh JW; Park YS; Park JO; Kim ST
Eur Radiol; 2017 Jul; 27(7):3088-3096. PubMed ID: 27815722
[TBL] [Abstract][Full Text] [Related]
27. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy.
Dudeck O; Zeile M; Wybranski C; Schulmeister A; Fischbach F; Pech M; Wieners G; Rühl R; Grosser O; Amthauer H; Ricke J
Eur Radiol; 2010 Nov; 20(11):2699-706. PubMed ID: 20563725
[TBL] [Abstract][Full Text] [Related]
28. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
29. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: A comparison with unenhanced and Gd-EOB-DTPA enhanced MRI.
Colagrande S; Castellani A; Nardi C; Lorini C; Calistri L; Filippone A
Eur J Radiol; 2016 May; 85(5):1027-34. PubMed ID: 27130067
[TBL] [Abstract][Full Text] [Related]
30. Advantage of High b Value Diffusion-Weighted Imaging for Differentiation of Hemangioblastoma from Brain Metastases in Posterior Fossa.
Onishi S; Hirose T; Takayasu T; Nosaka R; Kolakshyapati M; Saito T; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2017 May; 101():643-650. PubMed ID: 28179177
[TBL] [Abstract][Full Text] [Related]
31. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
[TBL] [Abstract][Full Text] [Related]
32. Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
Torkzad MR; Riddell AM; Chau I; Cunningham D; Koh DM
AJR Am J Roentgenol; 2021 Mar; 216(3):669-676. PubMed ID: 33502225
[No Abstract] [Full Text] [Related]
33. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Kitamura T; Faima Z; Fukushima K; Araki T; Iino H; Mori Y; Fujii H
J Magn Reson Imaging; 2010 Nov; 32(5):1132-40. PubMed ID: 21031519
[TBL] [Abstract][Full Text] [Related]
34. Value of multiple models of diffusion-weighted imaging to predict hepatic lymph node metastases in colorectal liver metastases patients.
Zhu HB; Zhao B; Li XT; Zhang XY; Yao Q; Sun YS
World J Gastroenterol; 2024 Jan; 30(4):308-317. PubMed ID: 38313236
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-Related MRI Parameters for Assessing Early Treatment Response of Liver Metastases to Cytotoxic Therapy in Colorectal Cancer.
Kim JH; Joo I; Kim TY; Han SW; Kim YJ; Lee JM; Han JK
AJR Am J Roentgenol; 2016 Sep; 207(3):W26-32. PubMed ID: 27303858
[TBL] [Abstract][Full Text] [Related]
36. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study.
Katharina Ingenerf M; Karim H; Fink N; Ilhan H; Ricke J; Treitl KM; Schmid-Tannwald C
Acta Radiol; 2022 Jul; 63(7):877-888. PubMed ID: 34225464
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted MRI as a screening tool for hepatocellular carcinoma in cirrhotic livers: correlation with explant data-a pilot study.
McNamara MM; Thomas JV; Alexander LF; Little MD; Bolus DN; Li YE; Morgan DE
Abdom Radiol (NY); 2018 Oct; 43(10):2686-2692. PubMed ID: 29500648
[TBL] [Abstract][Full Text] [Related]
38. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
39. Multi-sequence MRI radiomics of colorectal liver metastases: Which features are reproducible across readers?
van der Reijd DJ; Chupetlovska K; van Dijk E; Westerink B; Monraats MA; Van Griethuysen JJM; Lambregts DMJ; Tissier R; Beets-Tan RGH; Benson S; Maas M
Eur J Radiol; 2024 Mar; 172():111346. PubMed ID: 38309217
[TBL] [Abstract][Full Text] [Related]
40. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
Rühl R; Lüdemann L; Czarnecka A; Streitparth F; Seidensticker M; Mohnike K; Pech M; Wust P; Ricke J
Radiat Oncol; 2010 May; 5():44. PubMed ID: 20507615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
